Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.

Fund Raising View source PDF Explain this filing

BETA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹1350.70

prior close

₹1360.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.6%-0.5% vs market

Pharmaceuticals peers, median of 166sector+0.8%+0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.0

15m

+0.0

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+1.6-0.5+0.8+0.3

Next day

+4.6+2.3+2.3+1.4+3.2

+6.6+2.3+4.3+1.4+5.2

+6.0+1.6+4.4+0.8+5.3

+5.1+0.5+4.6+0.4+4.7

+4.4+1.6+2.8+0.8+3.6

+10.6+2.7+7.9+0.5+10.1

15d

+37.8+5.4+32.4+1.3+36.5

+53.2+7.3+46.0+3.4+49.8

+65.0+8.6+56.4+5.5+59.4

+70.1+13.0+57.1+8.2+61.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Beta Drugs Limited's board approved the allotment of 6,65,314 equity shares of ₹10 each to Healthquad Trust II and Inti Capital VCC - Inti Capital I. These shares were issued upon conversion of 6,65,314 Compulsory Convertible Debentures that were originally allotted on November 27, 2024. The conversion happened at a 1:1 ratio, meaning each CCD was converted into one equity share. This represents conversion of previous investments by these investors into equity, which will result in dilution for existing shareholders.

Likely market impact

Existing shareholders will face dilution as the equity share capital increases by 6,65,314 shares. The conversion signals that institutional investors (Healthquad Trust II and Inti Capital) have chosen to convert their debt instruments into equity, which could be seen as a positive sign of investor confidence in the company's prospects.